Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common stock, $0.0001 par value
2024-02-26$0.91/sh+2,500$2,275→ 18,990 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.